⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Apimeds Pharmaceuticals US, Inc.

$4.20
+0.08 (+1.94%)

Volume:

14.686K ($61.68K)

Market Capitalization:

$6.34M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Apimeds Pharmaceuticals US Market Segments

Regular Trading Hours

+0.04(+0.96%)
Open$4.16
Close$4.20
Low$4.12
Low Change-0.04 (-0.96%)
High$4.35
High Change+0.19 (+4.57%)
Range$0.23
Volume14.374K
Dollar Volume$60.37K

Premarket

+0.00(+0.00%)
Open$4.21
Close$4.21
Low$4.21
Low Change0.00 (0.00%)
High$4.21
High Change+0.00 (+0.00%)
Range$0.00
Volume312
Dollar Volume$1.31K

Overnight

*No Trades in Segment

After Hours Yesterday

-0.10(-2.28%)
Open$4.39
Close$4.29
Low$4.18
Low Change-0.21 (-4.78%)
High$4.39
High Change+0.00 (+0.00%)
Range$0.21
Volume1.35K
Dollar Volume$5.79K

Regular Trading Hours Yesterday

-0.13(-3.06%)
Open$4.25
Close$4.12
Low$4.00
Low Change-0.25 (-5.88%)
High$4.41
High Change+0.16 (+3.87%)
Range$0.41
Volume83.205K
Dollar Volume$342.80K

Premarket Yesterday

+0.07(+1.66%)
Open$4.22
Close$4.29
Low$4.20
Low Change-0.02 (-0.47%)
High$4.50
High Change+0.28 (+6.64%)
Range$0.30
Volume4.738K
Dollar Volume$20.33K

Apimeds Pharmaceuticals US News

There is no current news for this stock at the moment.

Apimeds Pharmaceuticals US Top Trades

Apimeds Pharmaceuticals US's top trade so far today returned +4.57%, while the top short trade returned -3.45%.

Apimeds Pharmaceuticals US Moving Averages

5 Day Moving Average (SMA5)$4.52
10 Day Moving Average (SMA10)$4.97
20 Day Moving Average (SMA20)$4.50
50 Day Moving Average (SMA50)$3.91
100 Day Moving Average (SMA100)$2.88
200 Day Moving Average (SMA200)$2.29

Apimeds Pharmaceuticals US Statistics

Average Volume (30 Days)7.81M
P/E Ratio (Current)-.13
EPS (Current)-$38.55
Dividend Yield0.00%
Free Cash Flow-$13.33M
Cash Ratio0.01
Current Ratio0.51
Quick Ratio0.51
Debt to Equity0.08
Enterprise Value$16.20M
EV to EBITDA-0.59
EV to Sales—
Price to Book0.07
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-0.46%
Return on Equity-0.55%

Apimeds Pharmaceuticals US Stock Splits

There has been 1 stock split for Apimeds Pharmaceuticals US (APUS). The reverse stock split occured on March 26, 2026 and reduced the outstanding shares at a ratio of 10:1.

DateTypeRatio
Mar 26, 2026Reverse10:1

Apimeds Pharmaceuticals US Dividends

There have been no dividends for Apimeds Pharmaceuticals US (APUS).